24 Jul 2020 Gilead en Galapagos kondigen positieve Europese CHMP opinie aan voor Jyseleca® (Filgotinib) voor de behandeling van volwassenen met matige tot ernstige reumatoïde artritis Member news
02 Jul 2020 Aligos Therapeutics and KU Leuven announce collaboration for the development of a therapeutic candidate targeting Coronavirus Member news
26 Jun 2020 US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings Member news
17 Jun 2020 eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept Member news
08 Jun 2020 New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis Member news
04 Jun 2020 Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis Member news
26 May 2020 argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis Member news
21 May 2020 Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
